Hantavirus FAQ
This Frequently Asked Questions (FAQ) page provides hospital infection control professionals with essential information about Hantavirus, with particular emphasis on the Andes strain. It covers transmission routes, clinical considerations, and practical infection control strategies, including the critical role of maintaining clean and sanitary air environments in preventing nosocomial transmission.
Hantavirus Basics
What is Hantavirus?
Hantavirus is a genus of viruses belonging to the Bunyaviridae family. These viruses cause severe respiratory and hemorrhagic diseases in humans. The most clinically significant strains include Hantavirus pulmonary syndrome (HPS) caused by the Sin Nombre virus in North America, and Hantavirus cardiopulmonary syndrome (HCPS) caused by the Andes virus in South America. The Andes strain is of particular concern for healthcare facilities due to its ability to cause human-to-human transmission, setting it apart from most other Hantavirus strains.
What is the Andes strain and why is it significant?
The Andes virus (ANDV) is a Hantavirus strain identified in Argentina and Chile in the 1990s. It is particularly significant because it is the only Hantavirus strain documented to cause sustained person-to-person transmission, primarily through respiratory droplets. This transmission capability poses unique challenges for healthcare facilities and requires specialized infection control protocols. HCPS caused by the Andes strain carries a mortality rate of 30-50% in hospitalized patients, making infection prevention critically important.
How does Hantavirus differ from other respiratory viruses?
Unlike many common respiratory viruses, Hantavirus infections typically originate from infected rodent reservoirs, particularly deer mice, cotton rats, and rice rats. Infections are usually acquired through inhalation of aerosolized virus from contaminated rodent excreta. The Andes strain is unique among Hantaviruses in its ability to be transmitted between humans through respiratory droplets, making it more similar to influenza and COVID-19 in this aspect. This human-to-human transmission capability requires similar respiratory isolation protocols.
Transmission Routes
How is Hantavirus transmitted?
Hantavirus is primarily transmitted through inhalation of aerosolized virus particles from infected rodent droppings, urine, or saliva. Secondary transmission routes include direct contact with infected rodent tissues and, in rare cases, ingestion of contaminated food. The Andes strain represents a critical exception: it can be transmitted from person-to-person through respiratory droplets and potentially through contact with infected blood or bodily fluids during the acute illness phase.
What is the risk of person-to-person transmission in a hospital setting?
Person-to-person transmission of the Andes strain occurs through respiratory droplets expelled during coughing, sneezing, and mechanical ventilation procedures. Healthcare workers and other hospitalized patients in close proximity to a confirmed or suspected Andes virus case are at risk. The Andes strain has been responsible for documented nosocomial outbreaks in South America, with secondary cases occurring in healthcare workers and family members. This distinguishes it from other Hantavirus strains and necessitates stringent respiratory isolation protocols in hospital environments.
What is the incubation period for Hantavirus?
The incubation period for Hantavirus varies from 1-4 weeks, with an average of 2-3 weeks. Some cases may have incubation periods extending to 5 weeks. During this asymptomatic phase, infected individuals may unknowingly expose others to the virus. Healthcare workers should maintain a high index of suspicion for Hantavirus in patients with unexplained pneumonia or acute respiratory distress, even without obvious rodent exposure history.
Infection Control Recommendations
What respiratory precautions should be implemented for suspected Andes virus cases?
Standard precautions, contact precautions, and respiratory precautions (airborne precautions recommended) should be implemented immediately upon suspicion of Hantavirus, particularly the Andes strain. This includes the use of N95 or higher-level respirators for healthcare workers, patient isolation in single rooms with negative pressure ventilation when possible, and limitations on visitor access. Respiratory isolation should be maintained throughout the acute illness phase, typically 1-2 weeks after symptom onset.
What personal protective equipment (PPE) is recommended?
Healthcare workers caring for suspected or confirmed Andes virus patients should wear: (1) N95 or higher-level respirators fitting snugly over nose and mouth; (2) Eye protection (face shield or goggles) to prevent droplet splashes; (3) Gowns to protect skin and clothing; (4) Double gloves when handling blood or bodily fluids; (5) Shoe covers when significant blood or bodily fluid contamination is anticipated. PPE should be donned before entering the patient room and doffed carefully following standard protocols to prevent self-contamination.
How should healthcare workers be educated about Hantavirus?
All healthcare workers should receive training on Hantavirus recognition, transmission routes, appropriate isolation protocols, and proper use of respiratory protection. Training should emphasize the unique person-to-person transmission capability of the Andes strain and the heightened risk during aerosol-generating procedures such as intubation, suctioning, and nebulizer treatments. Regular competency assessments and refresher training ensure consistent adherence to infection control practices.
What precautions are needed during aerosol-generating procedures?
Aerosol-generating procedures such as intubation, extubation, suctioning, non-invasive positive pressure ventilation, and high-flow oxygen therapy carry heightened transmission risk for Andes virus. These procedures should be performed only when clinically necessary, in dedicated negative-pressure rooms when available, with enhanced PPE including airborne protection. Consider postponing non-urgent aerosol-generating procedures for stable patients until Hantavirus has been ruled out. Minimize the number of personnel present during these procedures.
Air Quality, Sanitation, and Environmental Controls
Why is maintaining clean and sanitary air critical for preventing Hantavirus transmission?
The Andes strain spreads primarily through respiratory droplets and aerosols expelled by infected individuals. Contaminated air poses a direct transmission risk to healthcare workers, patients, and visitors in hospital environments. Maintaining clean, sanitary air through proper ventilation, filtration, and air treatment significantly reduces the concentration of viral particles in shared air spaces. Superior air quality directly translates to reduced infection risk and is a cornerstone of preventing nosocomial Hantavirus transmission, particularly in areas where susceptible patients receive care.
What HVAC standards should be maintained for isolation rooms?
Isolation rooms for confirmed or suspected Andes virus cases should maintain negative pressure relative to adjacent spaces (minimum 0.02 inches of water pressure differential). Air exchange rates should be at least 12 air changes per hour (ACH), with 15-20 ACH preferred for enhanced safety. Air should be exhausted directly to the outside, away from building air intakes and occupied spaces. HEPA filtration should be used on room exhaust systems. Room ventilation should be verified through pressure monitoring, smoke testing, and regular maintenance to ensure compliance with these standards.
What role do portable air filtration systems play in infection control?
Portable high-efficiency particulate air (HEPA) filtration units and advanced air treatment systems provide supplemental protection in healthcare settings, particularly in areas where existing HVAC systems may be inadequate. These systems can rapidly reduce airborne viral particle concentrations in patient care areas. Systems utilizing HEPA filtration, activated carbon, and UV-C or photocatalytic technologies offer multi-layered protection against Hantavirus and other airborne pathogens. Portable systems are particularly valuable for rapid isolation setup, surge capacity scenarios, and in facilities where architectural modifications are not feasible.
How important is surface sanitation in preventing Hantavirus transmission?
While Hantavirus primarily spreads through respiratory droplets and aerosols, contaminated surfaces in healthcare settings can harbor viral particles from respiratory secretions and blood. All high-touch surfaces in patient rooms (bedrails, door handles, remote controls, ventilators, monitors) should be cleaned and disinfected regularly using EPA-approved disinfectants effective against enveloped viruses (EPA List Q). Environmental surfaces should be cleaned at least twice daily, with more frequent cleaning when visible contamination occurs. This dual approach, controlling airborne transmission through air quality management while maintaining rigorous surface sanitation, provides comprehensive environmental protection.
What cleaning protocols should be implemented for patient care equipment?
Respiratory equipment (ventilators, tubing, masks), monitoring equipment, and non-critical medical devices used in Hantavirus patient care must be cleaned and disinfected between uses and at the end of each shift. Use EPA-approved disinfectants from List Q; allow appropriate contact times. Semi-critical equipment should undergo high-level disinfection or sterilization per manufacturer guidelines and infection control standards. Reusable respiratory protection equipment should be cleaned according to manufacturer specifications. All staff should be trained on proper cleaning and disinfection procedures to prevent cross-contamination.
Recognition and Clinical Considerations
What clinical signs should prompt suspicion of Andes virus?
Clinical suspicion for Andes virus should be heightened in patients presenting with acute fever (>38.5°C), myalgias, back pain, headache, and cough or dyspnea that rapidly progress to respiratory compromise within 4-10 days of symptom onset. Distinctive findings include relative bradycardia, thrombocytopenia, and elevated hematocrit. Progression to acute respiratory distress syndrome with bilateral pulmonary infiltrates and non-cardiogenic pulmonary edema is characteristic. Cases linked to contact with infected individuals (healthcare workers, family members) or with known Andes virus exposure should raise clinical suspicion even in the absence of rodent exposure history.
What diagnostic tests are available for Andes virus?
Diagnosis of Andes virus can be made through: (1) RT-PCR on respiratory specimens, blood, or urine specimens, which is most sensitive during the acute phase; (2) Serologic testing (IgM and IgG antibodies), which becomes positive during the second week of illness; (3) Immunohistochemical staining on tissue samples from fatal cases. RT-PCR is the preferred diagnostic method in the acute phase for guiding isolation decisions. Testing should be coordinated with local public health authorities and referral laboratories experienced with Hantavirus diagnostics.
Special Populations and Scenarios
What are the considerations for pregnant healthcare workers or patients?
Pregnant healthcare workers should understand that while comprehensive safety data is limited, Hantavirus poses potential risks to both mother and fetus. Pregnant workers should be reassigned from direct care of confirmed or suspected Andes virus patients if feasible. Pregnant patients with suspected Hantavirus require careful management given the increased risk of severe illness during pregnancy and potential vertical transmission risks. Consultation with maternal-fetal medicine specialists and infectious disease experts is recommended.
How should hospital surge capacity plans address Hantavirus outbreaks?
Hospitals should include Hantavirus response in their infection control surge plans, including: (1) Identification and stockpiling of N95 respirators and other PPE adequate for sustained respiratory isolation protocols; (2) Agreements for alternative air filtration and negative-pressure room setup capacity; (3) Clear isolation protocols and staff training; (4) Arrangements with reference laboratories for diagnostic testing; (5) Coordination plans with public health authorities; (6) Communication protocols for staff and patients.
Additional Resources
For more information about Hantavirus recognition and management, healthcare facilities should consult:
- CDC Division of Viral Diseases (Hantavirus) guidance
- CDC Infection Control Precautions recommendations
- Local and regional public health department authorities
- Your facility’s infection prevention and epidemiology team
Conclusion
The Andes strain of Hantavirus presents unique challenges to healthcare facilities due to its person-to-person transmission capability. Successful prevention of nosocomial transmission requires a comprehensive, multi-faceted approach combining appropriate respiratory isolation protocols, rigorous PPE use, healthcare worker training, and, critically, the maintenance of clean, sanitary air environments through superior ventilation, filtration, and air treatment technologies. Aerobiotix solutions provide hospitals with the advanced air quality management necessary to reduce airborne viral contamination and protect patients, staff, and visitors. By implementing the recommendations on this page in conjunction with advanced air quality solutions, healthcare facilities can significantly reduce the risk of Hantavirus transmission and enhance overall infection control.
